It’s easy to concentrate on the gloom surrounding scaling a business right now: especially as the threat of a global trade war adds to the other layers of tax, regulation, and consumer outlook uncertainty.
But Sir Peter Donnelly, who co-founded genetics analytic firm Genomics in 2014 with three colleagues from Oxford University and remains its chief executive, has another perspective.
